Distribusi Ameloblastoma Berdasarkan Usia, Jenis Kelamin, Lokasi dan Subtipe Histopatologi di RSUD A.W. Sjahranie Samarinda Tahun 2015-2020
Distribution of Ameloblastoma Based on Age, Gender, Location and Histopathology at RSUD A. W. Sjahranie Samarinda in the Period of 2015-2020
DOI:
https://doi.org/10.25026/jsk.v4i2.892Keywords:
Ameloblastoma, histopathology subtype, benign tumorAbstract
Ameloblastoma is one of the most common benign tumors of the oral cavity originating from odontogenic epithelium. This tumor is slow-growing but aggressive, locally invasive, has a high potential for recurrence, transforms into malignant and metastasizes. Risk factors such as tumor location, tumor size, patient age, radiographic appearance, a histopathology subtype, and selection of appropriate treatment correlate with recurrence in ameloblastoma. This study aimed to determine the distribution of ameloblastoma based on age, gender, location, and histopathology subtype. This research is quantitative research with a descriptive method using medical record data subjects and paraffin slides/blocks based on predetermined inclusion criteria. Data were grouped by age, gender, location and histopathology subtype. The results are presented in the form of tables and narratives. Based on the data obtained from 27 samples in this study, the age range category of 45-54 years was the age group with the most ameloblastoma found in 11 patients (40.74%). The number of males patients was 13 patients (48.15%) and 14 patients (51.95%) found on females. Most ameloblastomas were found in the mandible, with a total of 26 patients (96.30%). The most common histopathology subtypes were follicular and plexiform histopathology subtypes with 8 patients (29.63%) each.
References
[1] I. Allon, I. Kaplan, G. Gal, G. Chaushu, dan D. M. Allon, “The clinical characteristics of benign oral mucosal tumors,” Medicina Oral, Patologia Oral y Cirugia Bucal, vol. 19, no. 5, hlm. e438–e443, 2014, doi: 10.4317/medoral.19387.
[2] R. Wihardja dan R. Setiadhi, “Konsdisi kesehatan gigi dan mulut siswa SDK Yahya Oral Health Condition of the Yahya Christian Elementary School Students,” Jurnal Kedokteran Gigi Universitas Padjadjaran, vol. 30, no. 1, hlm. 26–26, 2018, doi: 10.24198/jkg.v30i1.16247.
[3] O. A. Effiom, O. M. Ogundana, A. O. Akinshipo, dan S. O. Akintoye, “Ameloblastoma: current etiopathological concepts and management,” Oral Diseases, vol. 24, no. 3, hlm. 307–316, 2018, doi: 10.1111/odi.12646.
[4] K. M. K. Masthan, N. Anitha, J. Krupaa, dan S. Manikkam, “Ameloblastoma,” Journal of Pharmacy and Bioallied Sciences, vol. 7, no. April, hlm. S167–S170, 2015, doi: 10.4103/0975-7406.155891.
[5] A. D. Petrovic dkk., “Ameloblastomas of the mandible and maxilla,” Ear, nose, & throat journal, vol. 97(7), hlm. E26–E32, 2018, doi: 10.1177/014556131809700704.
[6] W. S.C dan M. J. Pharoah, Oral Radiology Principles and Interpretation, 7 ed. st. Louis: mosby, 2014.
[7] B. Bianchi dkk., “Mandibular resection and reconstruction in the management of extensive ameloblastoma,” Journal of Oral and Maxillofacial Surgery, vol. 71, no. 3, hlm. 528–537, 2013, doi: 10.1016/j.joms.2012.07.004.
[8] F. U. A. R dan R. Irfan, “Radiological analysis and postoperative evaluation of multilocular ameloblastoma in young patient through panoramic radiograph: a case report,” vol. 1, no. 3, 2019.
[9] A. C. McClary dkk., “Ameloblastoma: a clinical review and trends in management,” European Archives of Oto-Rhino-Laryngology, vol. 273, no. 7, hlm. 1649–1661, 2016, doi: 10.1007/s00405-015-3631-8.
[10] B. Neville, D. Damm, C. Allen, dan A. Chi, Neville Oral and Maxillofacial Pathology, 4ed. 2016.
[11] S. Balaji, Textbook ofOral and Maxillofacial Surgery, Third Edit. India: Elsevier, 2018.
[12] R. Rusdiana, S. U. Sandini, E. E. Vitria, dan T. I. Santoso, “Profile of Ameloblastoma from a Retrospective Study in Jakarta, Indonesia,” J Dent Indones, vol. 18, no. 2, hlm. 27–32, Agu 2011, doi: 10.14693/jdi.v18i2.60.
[13] N. Saghravanian, J. Salehinejad, N. Ghazi, M. Shirdel, dan M. Razi, “A 40-year Retrospective Clinicopathological Study of Ameloblastoma in Iran,” Asian Pacific Journal of Cancer Prevention, vol. 17, no. 2, hlm. 619–623, Mar 2016, doi: 10.7314/APJCP.2016.17.2.619.
[14] D. Hertog, E. Bloemena, Iha. Aartman, dan I. van der Waal, “Histopathology of ameloblastoma of the jaws; some critical observations based on a 40 years single institution experience,” Med Oral, hlm. e76–e82, 2012, doi: 10.4317/medoral.18006.
[15] A. Juliansyah, F. Briani, dan Division of Oncology Surgery, Department of Surgery, Faculty of Medicine, Universitas Indonesia, dr.Cipto Mangunkusumo General Hospital, Jakarta, “Characteristic of Mandibular Ameloblastoma and Postoperative Complication Influencing Factors in Cipto Mangunkusumo General Hospital January 2008 – December 2012,” NRJS, vol. 3, no. 1, hlm. 8–12, Apr 2018, doi: 10.7454/nrjs.v3i1.49.
[16] A. Medina, I. Velasco Martinez, B. McIntyre, dan R. Chandran, “Ameloblastoma: clinical presentation, multidisciplinary management and outcome,” Case Reports in Plastic Surgery and Hand Surgery, vol. 8, no. 1, hlm. 27–36, Jan 2021, doi: 10.1080/23320885.2021.1886854.
[17] M. Ruslin dkk., “The Epidemiology, treatment, and complication of ameloblastoma in East-Indonesia: 6 years retrospective study,” Med Oral, hlm. 0–0, 2017, doi: 10.4317/medoral.22185.
[18] G. B. Giraddi, K. Arora, dan A. M. Saifi, “Ameloblastoma: A retrospective analysis of 31 cases,” Journal of Oral Biology and Craniofacial Research, vol. 7, no. 3, hlm. 206–211, Sep 2017, doi: 10.1016/j.jobcr.2017.08.007.
[19] T. S. Santos, M. Piva, E. S. S. Andrade, A. Vajgel, R. de H. Vasconcelos, dan P. R. Martins-Filho, “Ameloblastoma in the Northeast region of Brazil: A review of 112 cases,” J Oral Maxillofac Pathol, vol. 18, no. 4, hlm. 66, 2014, doi: 10.4103/0973-029X.141368.
[20] K. Dhanuthai dkk., “Ameloblastoma: a multicentric study,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 113, no. 6, hlm. 782–788, Jun 2012, doi: 10.1016/j.oooo.2012.01.011.
[21] H. Mortazavi dan M. Baharvand, “Jaw lesions associated with impacted tooth: A radiographic diagnostic guide,” hlm. 11, 2016.
[22] Z. Evangelou dkk., “Maxillary Ameloblastoma: A Review With Clinical, Histological and Prognostic Data of a Rare Tumor,” In Vivo, vol. 34, no. 5, hlm. 2249–2258, 2020, doi: 10.21873/invivo.12035.
[23] A. H. Malik, S. W. Andrabi, A. A. Shah, A. L. Najar, dan S. Hassan, “Ameloblastoma: A Clinicopathological Retrospective study .,” hlm. 3.
[24] A. M. H. Cadavid, J. P. Araujo, C. M. Coutinho-Camillo, S. Bologna, C. A. L. Junior, dan S. V. Lourenço, “Ameloblastomas: current aspects of the new WHO classification in an analysis of 136 cases,” Surg Exp Pathol, vol. 2, no. 1, hlm. 17, Des 2019, doi: 10.1186/s42047-019-0041-z.
[25] Liu, Zhegi, Yang, rong, Gavarapu, Sandhyang, Peng, Canbang, Ji, Tong, dan Cao, Wei, “Recurrence and cancerization of ameloblastoma: multivariate analysis of 87 recurrent craniofacial ameloblastoma to assess risk factors associated with early recurrence and secondary ameloblastic carcinoma,” vol. 3, hlm. 189–195, Jun 2017, doi: 10.21147/j.issn.1000-9604.2017.03.04.
[2] R. Wihardja dan R. Setiadhi, “Konsdisi kesehatan gigi dan mulut siswa SDK Yahya Oral Health Condition of the Yahya Christian Elementary School Students,” Jurnal Kedokteran Gigi Universitas Padjadjaran, vol. 30, no. 1, hlm. 26–26, 2018, doi: 10.24198/jkg.v30i1.16247.
[3] O. A. Effiom, O. M. Ogundana, A. O. Akinshipo, dan S. O. Akintoye, “Ameloblastoma: current etiopathological concepts and management,” Oral Diseases, vol. 24, no. 3, hlm. 307–316, 2018, doi: 10.1111/odi.12646.
[4] K. M. K. Masthan, N. Anitha, J. Krupaa, dan S. Manikkam, “Ameloblastoma,” Journal of Pharmacy and Bioallied Sciences, vol. 7, no. April, hlm. S167–S170, 2015, doi: 10.4103/0975-7406.155891.
[5] A. D. Petrovic dkk., “Ameloblastomas of the mandible and maxilla,” Ear, nose, & throat journal, vol. 97(7), hlm. E26–E32, 2018, doi: 10.1177/014556131809700704.
[6] W. S.C dan M. J. Pharoah, Oral Radiology Principles and Interpretation, 7 ed. st. Louis: mosby, 2014.
[7] B. Bianchi dkk., “Mandibular resection and reconstruction in the management of extensive ameloblastoma,” Journal of Oral and Maxillofacial Surgery, vol. 71, no. 3, hlm. 528–537, 2013, doi: 10.1016/j.joms.2012.07.004.
[8] F. U. A. R dan R. Irfan, “Radiological analysis and postoperative evaluation of multilocular ameloblastoma in young patient through panoramic radiograph: a case report,” vol. 1, no. 3, 2019.
[9] A. C. McClary dkk., “Ameloblastoma: a clinical review and trends in management,” European Archives of Oto-Rhino-Laryngology, vol. 273, no. 7, hlm. 1649–1661, 2016, doi: 10.1007/s00405-015-3631-8.
[10] B. Neville, D. Damm, C. Allen, dan A. Chi, Neville Oral and Maxillofacial Pathology, 4ed. 2016.
[11] S. Balaji, Textbook ofOral and Maxillofacial Surgery, Third Edit. India: Elsevier, 2018.
[12] R. Rusdiana, S. U. Sandini, E. E. Vitria, dan T. I. Santoso, “Profile of Ameloblastoma from a Retrospective Study in Jakarta, Indonesia,” J Dent Indones, vol. 18, no. 2, hlm. 27–32, Agu 2011, doi: 10.14693/jdi.v18i2.60.
[13] N. Saghravanian, J. Salehinejad, N. Ghazi, M. Shirdel, dan M. Razi, “A 40-year Retrospective Clinicopathological Study of Ameloblastoma in Iran,” Asian Pacific Journal of Cancer Prevention, vol. 17, no. 2, hlm. 619–623, Mar 2016, doi: 10.7314/APJCP.2016.17.2.619.
[14] D. Hertog, E. Bloemena, Iha. Aartman, dan I. van der Waal, “Histopathology of ameloblastoma of the jaws; some critical observations based on a 40 years single institution experience,” Med Oral, hlm. e76–e82, 2012, doi: 10.4317/medoral.18006.
[15] A. Juliansyah, F. Briani, dan Division of Oncology Surgery, Department of Surgery, Faculty of Medicine, Universitas Indonesia, dr.Cipto Mangunkusumo General Hospital, Jakarta, “Characteristic of Mandibular Ameloblastoma and Postoperative Complication Influencing Factors in Cipto Mangunkusumo General Hospital January 2008 – December 2012,” NRJS, vol. 3, no. 1, hlm. 8–12, Apr 2018, doi: 10.7454/nrjs.v3i1.49.
[16] A. Medina, I. Velasco Martinez, B. McIntyre, dan R. Chandran, “Ameloblastoma: clinical presentation, multidisciplinary management and outcome,” Case Reports in Plastic Surgery and Hand Surgery, vol. 8, no. 1, hlm. 27–36, Jan 2021, doi: 10.1080/23320885.2021.1886854.
[17] M. Ruslin dkk., “The Epidemiology, treatment, and complication of ameloblastoma in East-Indonesia: 6 years retrospective study,” Med Oral, hlm. 0–0, 2017, doi: 10.4317/medoral.22185.
[18] G. B. Giraddi, K. Arora, dan A. M. Saifi, “Ameloblastoma: A retrospective analysis of 31 cases,” Journal of Oral Biology and Craniofacial Research, vol. 7, no. 3, hlm. 206–211, Sep 2017, doi: 10.1016/j.jobcr.2017.08.007.
[19] T. S. Santos, M. Piva, E. S. S. Andrade, A. Vajgel, R. de H. Vasconcelos, dan P. R. Martins-Filho, “Ameloblastoma in the Northeast region of Brazil: A review of 112 cases,” J Oral Maxillofac Pathol, vol. 18, no. 4, hlm. 66, 2014, doi: 10.4103/0973-029X.141368.
[20] K. Dhanuthai dkk., “Ameloblastoma: a multicentric study,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 113, no. 6, hlm. 782–788, Jun 2012, doi: 10.1016/j.oooo.2012.01.011.
[21] H. Mortazavi dan M. Baharvand, “Jaw lesions associated with impacted tooth: A radiographic diagnostic guide,” hlm. 11, 2016.
[22] Z. Evangelou dkk., “Maxillary Ameloblastoma: A Review With Clinical, Histological and Prognostic Data of a Rare Tumor,” In Vivo, vol. 34, no. 5, hlm. 2249–2258, 2020, doi: 10.21873/invivo.12035.
[23] A. H. Malik, S. W. Andrabi, A. A. Shah, A. L. Najar, dan S. Hassan, “Ameloblastoma: A Clinicopathological Retrospective study .,” hlm. 3.
[24] A. M. H. Cadavid, J. P. Araujo, C. M. Coutinho-Camillo, S. Bologna, C. A. L. Junior, dan S. V. Lourenço, “Ameloblastomas: current aspects of the new WHO classification in an analysis of 136 cases,” Surg Exp Pathol, vol. 2, no. 1, hlm. 17, Des 2019, doi: 10.1186/s42047-019-0041-z.
[25] Liu, Zhegi, Yang, rong, Gavarapu, Sandhyang, Peng, Canbang, Ji, Tong, dan Cao, Wei, “Recurrence and cancerization of ameloblastoma: multivariate analysis of 87 recurrent craniofacial ameloblastoma to assess risk factors associated with early recurrence and secondary ameloblastic carcinoma,” vol. 3, hlm. 189–195, Jun 2017, doi: 10.21147/j.issn.1000-9604.2017.03.04.
Downloads
Published
2022-04-30
How to Cite
Prinadira, S., Pramasari, C. N., & Samad, S. (2022). Distribusi Ameloblastoma Berdasarkan Usia, Jenis Kelamin, Lokasi dan Subtipe Histopatologi di RSUD A.W. Sjahranie Samarinda Tahun 2015-2020: Distribution of Ameloblastoma Based on Age, Gender, Location and Histopathology at RSUD A. W. Sjahranie Samarinda in the Period of 2015-2020. Jurnal Sains Dan Kesehatan, 4(2), 132–137. https://doi.org/10.25026/jsk.v4i2.892
Issue
Section
Articles
License
Copyright (c) 2022 Jurnal Sains dan Kesehatan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
